Breaking News

Formatech Donates Manufacturing Services To KAI Pharma

Formatech has selected KAI Pharmaceuticals’ KAI-4169 compound as the second clinical candidate to receive “free” manufacturing services under its Fillanthropy Program.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Formatech has selected KAI Pharmaceuticals’ KAI-4169 compound as the second clinical candidate to receive “free” manufacturing services under its Fillanthropy Program. KAI-4169 is being evaluated for the treatment of secondary hyperparathyroidism. Under the program, Formatech will donate the services required to aseptically fill and finish one lot of the drug product for use in KAI’s upcoming trials. Formatech plans to complete the production run of KAI-4169 in 1Q10. “We’re excited to have th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters